Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Invasive Ductal Breast Carcinoma|Invasive Lobular Breast Carcinoma
Interventions: DIAGNOSTIC_TEST: Radiomic, pathomic, and clinical markers
Sponsor: Sunnybrook Health Sciences Centre